ArticleNeurology. Clinical practice2025
Improving Folic Acid Supplementation for Women of Childbearing Age With Epilepsy.
Article in Neurology. Clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Birth complications such as autism and neurodevelopmental disabilities have an increased incidence in women with epilepsy (WWE), associated with the use of antiseizure medications, which can be mitigated with folic acid supplementation. This quality improvement (QI) project aimed to increase folic acid prescription rates from 18% to 50% for WWE between ages 18 and 47 seen at a level 4 epilepsy center. Methods: Data from the electronic health record (EHR) were obtained for women meeting inclusion criteria and were analyzed using descriptive statistics and QI methods. Four Plan-Do-Study-Act cycles were conducted during the intervention phase including provider education, implementation of an EHR screening tool, introducing patient educational flyers into clinic rooms, and reporting provider data to improve awareness of prescribing barriers. Results: Baseline data were collected from January through June 2022, identifying 1,032 patients meeting inclusion criteria. Interventions began in July 2022 and concluded in March 2023 during which time 1,252 patients met inclusion criteria. Folic acid prescription rates for WWE of childbearing age were increased from a baseline of 17.37% to 35.03%. Folic acid prescribing increased throughout the intervention phases. Improving provider awareness of their own prescribing habits along with educational interventions had the largest impact on increasing prescribing rates. All providers effectively received the initial educational intervention. Discussion: This QI study demonstrated that increasing provider education and awareness of current clinical practice guidelines increases folic acid prescribing rates for WWE of childbearing age without negatively affecting clinical workflow. This highlights the importance of provider education and ongoing monitoring of folic acid prescribing rates to improve patient outcomes and identifies a series of interventions that can be replicated in a variety of clinical settings.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.